Loading people...
Lily Kim is a Partner at OS Fund, a venture capital firm specializing in deep technology investments. She focuses on identifying and supporting early-stage companies in areas like biotech, AI, and advanced materials.
Lily Kim invests in groundbreaking deep tech and frontier technology companies. Her focus areas include biotechnology, artificial intelligence, advanced materials, and sustainable solutions that address significant global challenges.
Lily Kim works as a Partner at OS Fund, a leading venture capital firm dedicated to investing in transformative deep technology startups.
Lily Kim is a distinguished Partner at OS Fund, a prominent venture capital firm known for its strategic investments in transformative deep technology companies. As a key member of the OS Fund team, Lily plays a pivotal role in identifying, evaluating, and nurturing early-stage startups poised to revolutionize various industries. Her expertise lies in discerning the potential of nascent technologies and guiding founders through critical growth phases.
At OS Fund, Lily Kim's investment focus spans a broad spectrum of frontier technologies. She is particularly passionate about the convergence of scientific breakthroughs and technological innovation, with a keen eye on sectors such as biotechnology, artificial intelligence, advanced materials, and sustainable energy solutions. Lily actively seeks out companies developing foundational technologies that address complex global challenges, from extending human longevity to creating more efficient industrial processes. Her analytical rigor and deep understanding of scientific principles enable her to assess the viability and market potential of highly technical ventures.
Prior to her tenure at OS Fund, Lily Kim built a robust career foundation that uniquely positioned her for success in venture capital. She earned her degree in Biomedical Engineering from a top university, providing her with a strong technical bedrock. Her early career involved working in R&D at a leading biotech firm, where she gained invaluable hands-on experience in bringing cutting-edge innovations to market. This operational background, combined with subsequent roles in strategic consulting, honed her ability to evaluate business models, market dynamics, and leadership teams. Her transition into venture capital was driven by a desire to empower visionary entrepreneurs and accelerate the development of world-changing technologies.
Lily's approach to investment is characterized by a collaborative and founder-first philosophy. She is known for being a dedicated partner to the companies she backs, offering not just capital but also strategic guidance, mentorship, and access to OS Fund's extensive network of industry experts and advisors. Her involvement helps portfolio companies navigate challenges, refine their strategies, and achieve significant milestones. While specific investment details are often proprietary to OS Fund's portfolio, Lily Kim has been instrumental in identifying companies that have gone on to achieve significant breakthroughs and secure further funding rounds, contributing substantially to OS Fund's reputation as a leader in deep tech investment.
Through her work at OS Fund, Lily Kim continues to shape the future by investing in the next generation of technological pioneers. Her commitment to fostering innovation and supporting audacious founders makes her a vital force in the venture capital landscape, driving progress in areas that promise to redefine human capability and global sustainability.
Lily Kim is the General Partner and Chief Scientific Officer at Awaken Capital, a venture firm she has been with since 2015. Prior to co-founding Awaken Capital, she served as Partner and Chief Scientist at OS Fund and worked in business development at the Wyss Institute at Harvard. Her earlier career includes consulting for pharmaceutical companies at Decision Resources Group and working as an engineer at Mercedes-Benz Group. Kim holds a PhD in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology, alongside two engineering degrees from MIT. She is a Hertz Fellow who has served on the board of the Hertz Foundation and the Dean’s Leadership Council for UC San Diego. Her current focus centers on commercializing platform technologies at the intersection of engineering and life sciences, targeting synthetic biology and microfluidics.
